ArticleJournal of personalized medicine2023

miR-429 Suppresses Endometrial Cancer Progression and Drug Resistance via DDX53.

Kyung-Jun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.